Automated robotic arm–assisted FDG PET/CT-guided real-time bone biopsy is feasible and safe.
Using automated robotic arm–assisted FDG PET/CT-guided real-time bone biopsy provides clinicians with a very high diagnostic yield, according to a study published in the American Journal of Roentgenology.
Researchers from India performed a prospective study to determine the feasibility, safety, diagnostic performance, and clinical impact of real-time intraprocedural 18F-FDG PET/CT-guided automated robotic arm–assisted biopsy of hypermetabolic marrow or bone lesions.
Forty-seven men and 26 women who underwent PET/CT-guided biopsy of accessible hyper-metabolic marrow or bone lesions participated in the study.
Related article: Study: False-Positive Breast Biopsies Cost $2 Billion Annually
The automated robotic arm assisted with insertion of the biopsy needle into the target lesion and tissue sampling was performed at the site with the highest metabolic activity, after the needle position was confirmed using PET/CT. The researchers reviewed the results of histopathologic examination and clinical and imaging follow-up examinations, and they interviewed referring physicians to assess the clinical impact of interventions on treatment planning.
The results showed that 34 of the 73 patients assessed were oncology patients with suspected metastasis or residual disease. The pathologic diagnosis was not known for 38 patients; 7 with clinically suspected benign and 31 with malignant disease. The remaining patient was suspected of having skeletal sarcoidosis.
Thirty-nine marrow lesions and 34 bone lesions were targeted. All procedures were technically successful and safe, and no major complication was observed. Pathologic diagnosis was confirmed for 72 patients, for a diagnostic yield of 98.6%. For the 54 malignancies, results were:
The procedure was helpful in determining the treatment plan for 91.7% of patients.
The researchers concluded that use of an automated robotic arm–assisted FDG PET/CT-guided real-time bone biopsy was feasible and a safe intervention with a very high diagnostic yield. The procedure also had a major clinical impact on patients with minimal residual FDG uptake on end-of-treatment PET/CT and isolated suspected metastatic lesions.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.